Satsuma Pharmaceuticals, Inc.
STSA · NASDAQ
12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$70 | -$51 | -$48 | -$28 |
| Dep. & Amort. | $1 | $0 | $0 | $0 |
| Deferred Tax | $0 | $1 | $0 | -$0 |
| Stock-Based Comp. | $6 | $5 | $4 | $1 |
| Change in WC | $0 | $1 | $1 | -$2 |
| Other Non-Cash | $12 | $0 | $0 | $0 |
| Operating Cash Flow | -$52 | -$43 | -$42 | -$30 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$0 | -$2 | -$5 | -$1 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | -$48 | -$89 | -$34 | -$100 |
| Inv. Sales/Matur. | $92 | $40 | $97 | $5 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | $43 | -$51 | $58 | -$96 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $10 | $75 | $0 | $81 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $9 | $73 | -$2 | $143 |
| Financing Cash Flow | $9 | $73 | -$2 | $143 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | $1 | -$20 | $14 | $18 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $16 | $36 | $23 | $5 |
| End Cash | $16 | $16 | $36 | $23 |
| Free Cash Flow | -$52 | -$45 | -$47 | -$30 |